Albumin-globulin ratio (AGR), which is calculated as albumin / (total protein – albumin), is considered to be a strong prognostic tool for many cancers, as it combines the effectiveness of both albumin and globulin in predicting survival outcomes, particularly where solid tumors are involved (He et al., 2017a). The gene discussed is ALB; the disease is cancer.